Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

69.81USD
24 Oct 2014
Price Change (% chg)

$0.71 (+1.03%)
Prev Close
$69.10
Open
$69.35
Day's High
$69.91
Day's Low
$69.25
Volume
264,182
Avg. Vol
554,997
52-wk High
$77.30
52-wk Low
$64.79

BAX.N

Chart for BAX.N

About

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.... (more)

Overall

Beta: 0.71
Market Cap (Mil.): $37,825.05
Shares Outstanding (Mil.): 541.67
Dividend: 0.52
Yield (%): 2.98

Financials

  BAX.N Industry Sector
P/E (TTM): 21.86 32.72 34.06
EPS (TTM): 3.20 -- --
ROI: -- 8.76 17.45
ROE: -- 12.03 18.26
Search Stocks

Baxter's blood disorder drug gets FDA approval

- Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.

24 Oct 2014

UPDATE 1-Baxter's blood disorder drug gets FDA approval

Oct 24 - Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.

24 Oct 2014

Baxter's blood disorder drug gets FDA approval

Oct 24 - Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder.

24 Oct 2014

UPDATE 1-AstraZeneca cancer drug pipeline gets boost from European green light

* EMA also backs new drugs from Pfizer, Baxter, Clinuvel (Adds AstraZeneca comment, further details)

24 Oct 2014

Medical products push Baxter profit above estimate

- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

16 Oct 2014

UPDATE 1-Medical products push Baxter profit above estimate

Oct 16 - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

16 Oct 2014

Medical products push Baxter profit above estimate

Oct 16 - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales at its medical products business continued to grow.

16 Oct 2014

Baxter plans to open R&D center in Massachusetts for Baxalta spinoff

- Baxter International Inc on Monday said it would form a research and development center in Cambridge, Massachusetts, for the biopharmaceutical business it expects to spin off as a separate company in mid-2015.

29 Sep 2014

Baxter plans to open R&D center in Mass. for Baxalta spinoff

Sept 29 - Baxter International Inc on Monday said it would form a research and development center in Cambridge, Massachusetts, for the biopharmaceutical business it expects to spin off as a separate company in mid-2015.

29 Sep 2014

Kamada extends emphysema drug deal with Baxter through 2017

JERUSALEM - Israeli drugmaker Kamada said on Monday it extended an agreement with Baxter International to supply a drug to treat emphysema through 2017.

29 Sep 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $103.04 +0.41
Pfizer Inc. (PFE.N) $29.12 +0.52
Roche Holding Ltd. (ROG.VX) CHF278.00 -1.40
Abbott Laboratories (ABT.N) $42.45 +0.02
Boston Scientific Corporation (BSX.N) $12.99 +0.28
Wyeth Limited (WLED.NS) Rs1,033.15 +14.30
Hospira, Inc. (HSP.N) $52.24 +0.79

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks